MBMarcela Amitrano Bilobran

Marcela Amitrano Bilobran

*This is an algorithmically generated author record based on publicly available information.

Marcela Amitrano Bilobran has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Assessment of pain control in advanced cancer patients admitted to a palliative care unit

    by Marcela Amitrano Bilobran, Maria Fernanda Fernandes Duarte Costa, Andrezza Regadas Muniz, Patrícia Almeida Chelles, Edson Tavares da Silva Neto, Livia Costa de Oliveira, Simone Garruth dos Santos Machado Sampaio

    Introduction: Pain in people with cancer is prevalent and should have an individualized therapeutic plan. Objectives: To evaluate pain control in advanced cancer patients in a hospital palliative care unit. Methods: This is a cohort study, with prospective design, and quantitative approach, including advanced cancer patients admitted to a palliative care unit between June 2021 and February 2022 reporting pain. Data was collected from medical records and the Brief Pain Inventory (BPI) was used to assess pain on the first (D1), third (D3) and seventh (D7) day of hospitalization. Results: One hundred and four patients participated in the study. The most prevalent tumors were of the gastrointestinal tract (n=23; 22%), cervix (n=21; 20%) and breast (n=17; 16%). Abdomen was the most reported site of pain (n=34; 33%), with 50% classified as nociceptive pain, 39% neuropathic pain, and 11% mixed. On D1, 43% reported severe pain, 31% moderate, and 12% mild pain. There was an evolutionary drop in the percentage of severe pain (BPI3 70% to 37.1%; BPI4 12.6% to 5.4%; BPI5 42.5% to 13.5%; and BPI9 67.8% to 21.6%) according to the answers to all BPI questions during the period. On D1, D3 and D7, the average equipotent doses of oral morphine were 116 mg, 133 mg and 154 mg and the frequency of use of adjuvant use was 60%, 75%, and 69%, respectively. Conclusions: Pain was properly controlled and was related to the increased use of adjuvants, both for general and neuropathic pain. It was possible to observe that the use of adjuvants was related to better pain control.

  • Pain management effectiveness in advanced cancer: palliative care unit inpatient study

    by Simone Garruth dos Santos Machado Sampaio, Maria Fernanda Fernandes Duarte Costa, Marcela Amitrano Bilobran, Andrezza Helena Regadas Muniz, Patrícia Almeida Chelles, Julia Werneck Paulino Soares Souza, Livia Costa de Oliveira

    Objectives The aim of this study is to evaluate pain management adequacy based on the Pain Management Index (PMI), and its association with the Brief Pain Inventory (BPI) in advanced cancer inpatients to a palliative care unit. Methods This is a quantitative study concerning advanced cancer inpatients in a specialised palliative care unit between June 2021 and February 2022. The BPI was applied, and analgesia was observed on the first (D1), third (D3) and seventh (D7) day of hospitalisation. Adequate analgesia was considered when PMI≥0. Results A total of 104 patients were evaluated on D1, 68 on D3 and 45 on D7, with a mean age of 53.6 years (SD±14.1), most of them female (65.4%), with the most frequent primary tumour site located in the gastrointestinal tract (22.1%). The observed analgesia was adequate (PMI≥0) in 52.9% of all patients on D1, 95.6% on D3 and 100% on D7 (p value=0.012). The number of patients with moderate to severe pain interference in general activities (p value 0.012), mood (p value 0.014), walking ability (p value 0.047), normal work (p value 0.038) and pleasure of living (p value 0.025) decreased during hospitalisation. Conclusions Pain is a prevalent and impacting symptom in patients undergoing palliative care. Thus, objective analgesic adequacy assessments in specialised services are required. These findings reinforce the importance of effective pain control and corroborate the importance of employing objective tools in evaluating medical services and improving quality of life of patients.